|
1
|
López-Corral L, Gutiérrez NC, Vidriales
MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B and San Miguel JF:
The progression from MGUS to smoldering myeloma and eventually to
multiple myeloma involves a clonal expansion of genetically
abnormal plasma cells. Clin Cancer Res. 17:1692–1700. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DC, Weinhold N, Mitchell J, Chen
B, Stephens OW, Försti A, Nickel J, Kaiser M, Gregory WA, Cairns D,
et al: Genetic factors influencing the risk of multiple myeloma
bone disease. Leukemia. 30:883–888. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robey PG, Kuznetsov SA, Ren J, Klein HG,
Sabatino M and Stroncek DF: Generation of clinical grade human bone
marrow stromal cells for use in bone regeneration. Bone. 70:87–92.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raje N and Roodman GD: Advances in the
biology and treatment of bone disease in multiple myeloma. Clin
Cancer Res. 17:1278–1286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Qiu M, Dou C, Cao Z and Dong S:
MicroRNAs in bone balance and osteoporosis. Drug Dev Res.
76:235–245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang S, Deng Y, Gu P and Fan X: MicroRNAs
regulate bone development and regeneration. Int J Mol Sci.
16:8227–8253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lian JB, Stein GS, van Wijnen AJ, Stein
JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone
formation and homeostasis. Nat Rev Endocrinol. 8:212–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang W, Wu Y, Shiozaki Y, Sugimoto Y,
Takigawa T, Tanaka M, Matsukawa A and Ozaki T: miRNA-133a-5p
inhibits the expression of osteoblast differentiation-associated
markers by targeting the 3′ UTR of RUNX2. DNA Cell Biol.
37:199–209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JF, Fu WM, He ML, Xie WD, Lv Q, Wan
G, Li G, Wang H, Lu G, Hu X, et al: MiRNA-20a promotes osteogenic
differentiation of human mesenchymal stem cells by co-regulating
BMP signaling. RNA Biol. 8:829–838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma X, Li L, Jia T, Chen M, Liu G, Li C, Li
N and Yang D: miR-203a controls keratinocyte proliferation and
differentiation via targeting the stemness-associated factor ΔNp63
and establishing a regulatory circuit with SNAI2. Biochem Biophys
Res Commun. 491:241–249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu G, Lai P, Liu M, Xu L, Guo Z, Liu H, Li
W, Wang G, Yao X, Zheng J and Xu Y: miR-203a regulates
proliferation, migration, and apoptosis by targeting glycogen
synthase kinase-3β in human renal cell carcinoma. Tumor Biol.
35:11443–11453. 2014. View Article : Google Scholar
|
|
13
|
Huo W, Du M, Pan X, Zhu X, Gao Y and Li Z:
miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma
cell growth and metastasis. FEBS Open Bio. 7:1085–1091. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang Y, Zheng L, Zhou J, Chen Y, Yang L,
Deng F and Hu Y: miR-203-3p participates in the suppression of
diabetes-associated osteogenesis in the jaw bone through targeting
Smad1. Int J Mol Med. 41:1595–1607. 2018.PubMed/NCBI
|
|
15
|
Shi YY, Wang GL, Yang HL, Lu SZ, Zhang Y
and Cai X: Repairing rabbit femur bone defects by porous silk
fibroin/hydroxyapatite combined with adipose-derived stromal cells.
J Clin Rehabil Tissue Eng Res. 14:1341–1344. 2010.
|
|
16
|
Langenbach F and Handschel J: Effects of
dexamethasone, ascorbic acid and β-glycerophosphate on the
osteogenic differentiation of stem cells in vitro. Stem Cell Res
Ther. 4:1172013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo J, Fei C, Zhao Y, Zhao S, Zheng Q, Su
J, Wu D, Li X and Chang C: Lenalidomide restores the osteogenic
differentiation of bone marrow mesenchymal stem cells from multiple
myeloma patients via deactivating Notch signaling pathway.
Oncotarget. 121:55405–55421. 2017.
|
|
19
|
Yaccoby S: Advances in the understanding
of myeloma bone disease and tumour growth. Br J Haematol.
149:311–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He X, Wang H, Jin T, Xu Y, Mei L and Yang
J: TLR4 activation promotes bone marrow MSC proliferation and
osteogenic differentiation via Wnt3a and Wnt5a signaling. PLoS One.
11:e01498762016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giuliani N, Rizzoli V and Roodman GD:
Multiple myeloma bone disease: Pathophysiology of osteoblast
inhibition. Blood. 108:3992–3996. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhuang W, Ge X, Yang S, Huang M, Zhuang W,
Chen P, Zhang X, Fu J, Qu J and Li B: Upregulation of lncRNA MEG3
promotes osteogenic differentiation of mesenchymal stem cells from
multiple myeloma patients by targeting BMP4 transcription. Stem
Cells. 33:1985–1997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tanaka Y, Nakayamada S and Okada Y:
Osteoblasts and osteoclasts in bone remodeling and inflammation.
Curr Drug Targets Inflamm Allergy. 4:325–328. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rodan GA and Martin TJ: Therapeutic
approaches to bone diseases. Science. 289:1508–1514. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pi C, Li YP, Zhou X and Gao B: The
expression and function of microRNAs in bone homeostasis. Front
Biosci (Landmark Ed). 20:119–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang Y, Zhang L, Tu T, Li Y, Murray D, Tu
Q and Chen JJ: MicroRNA-99a is a novel regulator of KDM6B-mediated
osteogenic differentiation of BMSCs. J Cell Mol Med. 22:2162–2176.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vishal M, Vimalraj S, Ajeetha R, Gokulnath
M, Keerthana R, He Z, Partridge NC and Selvamurugan N:
MicroRNA-590-5p stabilizes Runx2 by targeting Smad7 during
osteoblast differentiation. J Cell Physiol. 232:371–380. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao C, Yang S, Xu W, Shen JK, Ye S, Liu X,
Dong Z, Xiao B and Feng Y: MiR-708 promotes steroid-induced
osteonecrosis of femoral head, suppresses osteogenic
differentiation by targeting SMAD3. Sci Rep. 6:225992016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishibashi O, Ikegame M, Takizawa F,
Yoshizawa T, Moksed MA, Iizawa F, Mera H, Matsuda A and Kawashima
H: Endoglin is involved in BMP-2-induced osteogenic differentiation
of periodontal ligament cells through a pathway independent of
Smad-1/5/8 phosphorylation. J Cell Physiol. 222:465–473. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dexheimer V, Gabler J, Bomans K, Sims T,
Omlor G and Richter W: Differential expression of TGF-β superfamily
members and role of Smad1/5/9-signalling in chondral versus
endochondral chondrocyte differentiation. Sci Rep. 6:366552016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Sun W, Ma J, Pan Y, Wang L and
Zhang WB: Biglycan mediates suture expansion osteogenesis via
potentiation of Wnt/β-catenin signaling. J Biomech. 48:432–440.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen EEM, Zhang W, Ye CCY, Gao X, Jiang
LLJ, Zhao TTF, Pan ZZJ and Xue DDT: Knockdown of SIRT7 enhances the
osteogenic differentiation of human bone marrow mesenchymal stem
cells partly via activation of the Wnt/b-catenin signaling pathway.
Cell Death Dis. 8:e30422017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen LJ, Hu BB, Shi XL, Ren MM, Yu WB, Cen
SD, Hu RD and Deng H: Baicalein enhances the osteogenic
differentiation of human periodontal ligament cells by activating
the Wnt/β-catenin signaling pathway. Arch Oral Biol. 78:100–108.
2017. View Article : Google Scholar : PubMed/NCBI
|
